| 000 | 01413 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513064049.0 | ||
| 264 | 0 | _c19940617 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a1222-3891 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerold, A | |
| 245 | 0 | 0 |
_aZinc aspartate in vivo and in vitro modulation of reactive oxygen species production by human neutrophils and monocytes. _h[electronic resource] |
| 260 |
_bRoumanian archives of microbiology and immunology _c |
||
| 300 |
_a101-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aAspartic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aCells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aDigitonin _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xpharmacology |
| 650 | 0 | 4 |
_aLeukemia _xblood |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aZinc _xadministration & dosage |
| 650 | 0 | 4 |
_aZymosan _xpharmacology |
| 700 | 1 | _aBucurenci, N | |
| 700 | 1 | _aMazilu, E | |
| 700 | 1 | _aSzegli, G | |
| 700 | 1 | _aSidenco, L | |
| 700 | 1 | _aBaican, I | |
| 773 | 0 |
_tRoumanian archives of microbiology and immunology _gvol. 52 _gno. 2 _gp. 101-8 |
|
| 999 |
_c8185771 _d8185771 |
||